Sargramostim Injection |
GM-CSF; Leukine; Prokine |
Clinical Trial: Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
This study is no longer recruiting patients.
Purpose
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.
PURPOSE: Phase II trial to study the effectiveness of combining cytarabine and daunorubicin in treating older patients who have acute myeloid leukemia that has not been previously treated.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Myeloid Leukemia | Drug: cytarabine Drug: daunorubicin Drug: filgrastim Drug: sargramostim Procedure: biological response modifier therapy Procedure: chemotherapy Procedure: colony-stimulating factor therapy Procedure: cytokine therapy | Phase II |
MedlinePlus related topics: Bone Marrow Diseases; Immune System and Disorders; Leukemia, Adult Acute; Leukemia, Adult Chronic; Leukemia, Childhood; Lymphatic Diseases
Study Type: Interventional
Study Design: Treatment
Official Title: Phase II Study of Cytarabine and Daunorubicin as Induction Chemotherapy in Older Patients With Previously Untreated Non-M3 Acute Myeloid Leukemia
OBJECTIVES:
- Determine the efficacy of cytarabine and daunorubicin as induction chemotherapy in older patients with previously untreated non-M3 acute myeloid leukemia.
- Determine the frequency and severity of toxic effects of this regimen in these patients.
OUTLINE: This is a multicenter study.
Patients receive induction chemotherapy comprising daunorubicin IV continuously over days 1-3 and cytarabine IV continuously over days 1-7. Patients may be treated with a second course of induction chemotherapy beginning on day 19 if remission is not achieved at that time. Patients also receive filgrastim (G-CSF) or sargramostim (GM-CSF) IV or subcutaneously daily beginning on day 15 and continuing until blood counts recover.
Patients who achieve remission after the first or second course of induction chemotherapy receive consolidation chemotherapy comprising daunorubicin IV continuously over days 1 and 2 and cytarabine IV continuously over days 1-5. Beginning no earlier than day 19, patients receive a second course of consolidation chemotherapy.
Patients are followed every 3 months for 1 year, every 6 months for 1 year, and then annually for 3 years.
PROJECTED ACCRUAL: Approximately 30-55 patients will be accrued for this study within 8-9 months.
Eligibility
Ages Eligible for Study: 56 Years and above, Genders Eligible for Study: Both
Criteria
DISEASE CHARACTERISTICS:
- Histologically confirmed acute myeloid leukemia (AML)
- No M3 AML or blastic transformation of chronic myelogenous leukemia
- Must be enrolled on SWOG-9007 and S9910 protocols
PATIENT CHARACTERISTICS: Age:
- 56 and over
Performance status:
- Zubrod 0-3
Life expectancy:
- Not specified
Hematopoietic:
- Not specified
Hepatic:
- Bilirubin no greater than 2 times upper limit of normal (ULN)
- SGOT or SGPT no greater than 4 times ULN
Renal:
- Creatinine no greater than 1.5 times ULN OR
- Creatinine clearance greater than 40 mL/min
Cardiovascular:
- LVEF at least 50% by MUGA scan or 2-dimensional echocardiogram
- No unstable cardiac arrhythmias
- No unstable angina
Other:
- Not pregnant or nursing
- Fertile patients must use effective contraception
- No other prior malignancy within the past 5 years except adequately treated basal cell or squamous cell skin cancer, carcinoma in situ of the cervix, or other adequately treated stage I or II cancer in complete remission
PRIOR CONCURRENT THERAPY: Biologic therapy:
- Not specified
Chemotherapy:
- No prior systemic chemotherapy for acute leukemia
- Prior hydroxyurea to control high cell counts allowed
- Prior low-dose cytarabine (less than 100 mg/m^2/day) for treatment of myelodysplastic syndrome allowed
- At least 30 days since prior chemotherapy and recovered
- Concurrent single-dose intrathecal chemotherapy allowed
Endocrine therapy:
- Not specified
Radiotherapy:
- Not specified
Surgery:
- Not specified
Location Information
Alabama
MBCCOP - Gulf Coast, Mobile, Alabama, 36688, United States
Arizona
Arizona Cancer Center, Tucson, Arizona, 85724, United States
CCOP - Greater Phoenix, Phoenix, Arizona, 85006-2726, United States
Veterans Affairs Medical Center - Phoenix (Carl T. Hayden), Phoenix, Arizona, 85012, United States
Veterans Affairs Medical Center - Tucson, Tucson, Arizona, 85723, United States
Arkansas
University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States
Veterans Affairs Medical Center - Little Rock (McClellan), Little Rock, Arkansas, 72205, United States
California
CCOP - Bay Area Tumor Institute, Oakland, California, 94609-3305, United States
CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California, 95403, United States
Chao Family Comprehensive Cancer Center, Orange, California, 92868, United States
City of Hope Comprehensive Cancer Center, Duarte, California, 91010, United States
David Grant Medical Center, Travis Air Force Base, California, 94535, United States
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, 90095-1781, United States
University of California Davis Medical Center, Sacramento, California, 95817, United States
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, 90033-0804, United States
Veterans Affairs Medical Center - West Los Angeles, Los Angeles, California, 90073, United States
Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, 94553, United States
Colorado
University of Colorado Cancer Center, Denver, Colorado, 80010, United States
Veterans Affairs Medical Center - Denver, Denver, Colorado, 80220, United States
District of Columbia
MBCCOP - Howard University Cancer Center, Washington, District of Columbia, 20060, United States
Georgia
CCOP - Atlanta Regional, Atlanta, Georgia, 30342-1701, United States
Dwight David Eisenhower Army Medical Center, Fort Gordon, Georgia, 30905-5650, United States
Hawaii
Cancer Research Center of Hawaii, Honolulu, Hawaii, 96813-2424, United States
Tripler Army Medical Center, Honolulu, Hawaii, 96859-5000, United States
Illinois
CCOP - Central Illinois, Decatur, Illinois, 62526, United States
Loyola University Medical Center, Maywood, Illinois, 60153-5500, United States
MBCCOP - University of Illinois at Chicago, Chicago, Illinois, 60612-7323, United States
Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, 60612, United States
Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital), Hines, Illinois, 60141, United States
Kansas
CCOP - Wichita, Wichita, Kansas, 67214-3882, United States
University of Kansas Medical Center, Kansas City, Kansas, 66160-7353, United States
Veterans Affairs Medical Center - Wichita, Wichita, Kansas, 67218, United States
Kentucky
Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky, 40536-0084, United States
Veterans Affairs Medical Center - Lexington, Lexington, Kentucky, 40502-2236, United States
Louisiana
Louisiana State University Health Sciences Center - Shreveport, Shreveport, Louisiana, 71130-3932, United States
MBCCOP - LSU Medical Center, New Orleans, Louisiana, 70112, United States
Tulane University School of Medicine, New Orleans, Louisiana, 70112, United States
Veterans Affairs Medical Center - New Orleans, New Orleans, Louisiana, 70112, United States
Veterans Affairs Medical Center - Shreveport, Shreveport, Louisiana, 71130, United States
Massachusetts
Boston Medical Center, Boston, Massachusetts, 02118, United States
Veterans Affairs Medical Center - Boston (Jamaica Plain), Jamaica Plain, Massachusetts, 02130, United States
Michigan
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, 48201-1379, United States
CCOP - Ann Arbor Regional, Ann Arbor, Michigan, 48106, United States
CCOP - Beaumont, Royal Oak, Michigan, 48073-6769, United States
CCOP - Grand Rapids, Grand Rapids, Michigan, 49503, United States
Henry Ford Hospital, Detroit, Michigan, 48202, United States
Providence Hospital - Southfield, Southfield, Michigan, 48075-9975, United States
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109-0912, United States
Veterans Affairs Medical Center - Ann Arbor, Ann Arbor, Michigan, 48105, United States
Veterans Affairs Medical Center - Detroit, Detroit, Michigan, 48201-1932, United States
Minnesota
CCOP - Duluth, Duluth, Minnesota, 55805, United States
Mississippi
Keesler Medical Center - Keesler AFB, Keesler AFB, Mississippi, 39534-2576, United States
University of Mississippi Medical Center, Jackson, Mississippi, 39216-4505, United States
Veterans Affairs Medical Center - Biloxi, Biloxi, Mississippi, 39531-2410, United States
Veterans Affairs Medical Center - Jackson, Jackson, Mississippi, 39216, United States
Missouri
CCOP - Cancer Research for the Ozarks, Springfield, Missouri, 65807, United States
CCOP - Kansas City, Kansas City, Missouri, 64131, United States
CCOP - St. Louis-Cape Girardeau, Saint Louis, Missouri, 63141, United States
St. Louis University Health Sciences Center, Saint Louis, Missouri, 63110, United States
Veterans Affairs Medical Center - Kansas City, Kansas City, Missouri, 64128, United States
Montana
CCOP - Montana Cancer Consortium, Billings, Montana, 59101, United States
New Mexico
MBCCOP - University of New Mexico HSC, Albuquerque, New Mexico, 87131, United States
Veterans Affairs Medical Center - Albuquerque, Albuquerque, New Mexico, 87108-5138, United States
New York
Herbert Irving Comprehensive Cancer Center, New York, New York, 10032, United States
University of Rochester Medical Center, Rochester, New York, 14642, United States
Veterans Affairs Medical Center - Albany, Albany, New York, 12208, United States
North Carolina
CCOP - Southeast Cancer Control Consortium, Winston Salem, North Carolina, 27104-4241, United States
Ohio
Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, 43210-1240, United States
Barrett Cancer Center, Cincinnati, Ohio, 45267-0501, United States
CCOP - Columbus, Columbus, Ohio, 43206, United States
CCOP - Dayton, Kettering, Ohio, 45429, United States
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, 44195-9001, United States
Veterans Affairs Medical Center - Cincinnati, Cincinnati, Ohio, 45220-2288, United States
Veterans Affairs Medical Center - Dayton, Dayton, Ohio, 45428, United States
Oklahoma
Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, 73104, United States
Veterans Affairs Medical Center - Oklahoma City, Oklahoma City, Oklahoma, 73104, United States
Oregon
CCOP - Columbia River Program, Portland, Oregon, 97225, United States
Oregon Cancer Institute, Portland, Oregon, 97239, United States
Veterans Affairs Medical Center - Portland, Portland, Oregon, 97207, United States
South Carolina
CCOP - Greenville, Greenville, South Carolina, 29615, United States
CCOP - Upstate Carolina, Spartanburg, South Carolina, 29303, United States
Medical University of South Carolina, Charleston, South Carolina, 29425-0721, United States
Veterans Affairs Medical Center - Charleston, Charleston, South Carolina, 29401-5799, United States
Texas
Brooke Army Medical Center, Fort Sam Houston, Texas, 78234-6200, United States
CCOP - Scott and White Hospital, Temple, Texas, 76508, United States
University of Texas Health Science Center at San Antonio, San Antonio, Texas, 78284-7845, United States
University of Texas Medical Branch, Galveston, Texas, 77555-0565, United States
Veterans Affairs Medical Center - Houston, Houston, Texas, 77030, United States
Veterans Affairs Medical Center - San Antonio (Murphy), San Antonio, Texas, 78284, United States
Veterans Affairs Medical Center - Temple, Temple, Texas, 76504, United States
Utah
Huntsman Cancer Institute, Salt Lake City, Utah, 84112-5550, United States
Veterans Affairs Medical Center - Salt Lake City, Salt Lake City, Utah, 84148, United States
Washington
CCOP - Northwest, Tacoma, Washington, 98405-0986, United States
CCOP - Virginia Mason Research Center, Seattle, Washington, 98101, United States
Madigan Army Medical Center, Tacoma, Washington, 98431-5000, United States
Swedish Cancer Institute, Seattle, Washington, 98104, United States
University of Washington School of Medicine, Seattle, Washington, 98195, United States
Veterans Affairs Medical Center - Seattle, Seattle, Washington, 98108, United States
Thomas R. Chauncey, MD, PhD, Study Chair, University of Washington
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database
Record last reviewed: April 2003
Last Updated: October 13, 2004
Record first received: September 13, 2001
ClinicalTrials.gov Identifier: NCT00023777
Health Authority: Unspecified
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


